Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Transplant Medicine
Researchers report details of new studies and findings in the area of transplant medicine
February 14th, 2006
Transplant medicine data are the focus of recent research from the Netherlands, United States and Japan.
Study 1: Keratinocyte growth factor ameliorates acute graft-versus-host-disease in a novel nonmyeloablative haploidentical transplantation model.
"Allogeneic stem cell transplantations (SCT) are currently being used as a therapy for hematological malignancies, some solid tumors and nonmalignant bone marrow deficiencies. Nevertheless, clinical applicability is limited due to toxicity of conditioning regimens, graft-versus-host disease (GVHD) and the scarcity of HLA-identical family donors," scientists in Netherlands report.
...
Source: Cancer Weekly (2006-02-14)
|
